Skip to content

Sinus lift surgery with Dental Implants using Rosuvastatin and I-PRF

Evaluation of the efficacy of Rosuvastatin and injectable platelet rich fibrin and injectable platelet rich fibrin alone on sinus augmentation along with dental implants

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/08/044627
Enrollment
52
Registered
2022-08-04
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K068- Other specified disorders of gingiva and edentulous alveolar ridge

Interventions

Intervention1: Rosuvastatin and Injectable PRF: The agents are applied in gel forms only once at the time of surgery Intervention2: DR LAHARI BUGGAPATI: 52-4-6, FLAT NO 505 ARUNA TOWERS GUNADALA VIJA

Sponsors

Dr Lahari Buggapati
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: INCLUSION CRITERIA: 1. Patients age between 18-75 years. 2. Patients who are systemically healthy. 3. Exclusion Criteria 4. Adequate quality and quantity of bone. 5. Patients with good oral hygiene status. 6. Co-operative patient, willing for surgery and proper follow up.

Exclusion criteria

Exclusion criteria: EXCLUSIVE CRITERIA 1. Uncontrolled diabetes measured with HbA1c levels. 2. Pregnancy. 3. Poor oral hygiene. 4. Treatment with bisphosphonate drugs. 5. Severe bruxism and clenching. 6. Active infection or severe inflammation at the proposed implant site.

Design outcomes

Primary

MeasureTime frame
Bone height Timepoint: Baseline (before implant placement) Immediately after implant placement 1 year post operatively

Secondary

MeasureTime frame
Bone height Bone volume Sinus floor augmentation Bone densityTimepoint: Baseline (before implant placement) immediately after implant placement 1 year after implant placement

Countries

India

Contacts

Public ContactDr Lahari Buggapati

Government dental college and hospital kadapa

drnd2306@gmail.com9866995222

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026